Diabetic Macular Edema Market
Diabetic Macular Edema Market Global Industry Assessment & Forecast
#
Pages:
145
2021
Nov - 2021
VMR-2021-0525
Segments Covered
By
Indication Type, diffuse diabetic macular edema, focal diabetic macular edema
-
By
Treatment Type anti-VEGF, corticosteroids, laser photocoagulation therapy, other off-label drugs
-
By
End User hospitals, clinics, home care
Snapshot
 Forecast
Years:
|
2021 - 2028 |
 Historical
Years:
|
2016 - 2020 |
 Revenue
2021: |
3.7 Billion |
 Revenue 2028:
|
4.74 Billion |
 Revenue CAGR
(2021 - 2028): |
3.15 |
Fastest Growing Region (2022 -
2028)
|
North America |
Customization Offered
Cross-segment Market Size and
Analysis
for Mentioned Segments- Additional Company Profiles (Upto 5
With
No Cost)
- Additional Countries (Apart From
Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request
Customization Speak To
Analyst
Global Diabetic Macular Edema Market: Indication Type, Segment Analysis
-
- diffuse diabetic macular edema
- focal diabetic macular edema
Global Diabetic Macular Edema Market: Treatment Type Segment Analysis
-
- anti-VEGF
- corticosteroids
- laser photocoagulation therapy
- other off-label drugs
FAQ
Frequently Asked Question
What is the global demand for Diabetic Macular Edema in terms of revenue?
-
The global Diabetic Macular Edema valued at 3.7 Billion in 2020 and is expected to reach 4.74 Billion in 2028 growing at a CAGR of 3.15%.
Which are the prominent players in the market?
-
The prominent players in the market are Pfizer Inc., Bayer AG, Bausch & Lomb Incorporated, Allergan Inc., F. Hoffmann-La Roche Ltd., Regeneron Pharmaceuticals Inc., ShahidBeheshti University of Medical Sciences., Johns Hopkins University, Novartis AG, The National Eye Institute..
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 3.15% between 2021 and 2028.
What are the driving factors fueling the growth of the market?
-
The driving factors of the Diabetic Macular Edema include
- The increasing research & development activities for the treatment of diabetic macular edema is likely to accelerate the growth of the diabetic macular edema treatment market during the forecast period.
- Additionally, advancements in ophthalmic surgery techniques and R&D investment by pharmaceutical companies is further expected to boost the growth of the market in the years to come.
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Diabetic Macular Edema in 2020.
